Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)

ClinicalTrials.gov ID: NCT00394329

Public ClinicalTrials.gov record NCT00394329. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 9:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Childhood Asthma Research and Education (CARE) Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Asthma is a common, serious illness among children in the United States. It can be effectively controlled through the use of preventative medications and "rescue" medications, which are used to control symptoms. This study will evaluate the impact and severity of asthma exacerbations that occur in children with mild persistent asthma who are receiving various combinations of medications for daily and rescue use.

Study identification

NCT ID
NCT00394329
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
288 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
6 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2006
Primary completion
Nov 30, 2011
Completion
Nov 30, 2011
Last update posted
Jul 1, 2018

2006 – 2011

United States locations

U.S. sites
6
U.S. states
5
U.S. cities
6
Facility City State ZIP Site status
University of Arizona College of Medicine Tucson Arizona 85724
Los Angeles, Kaiser Permanente Allergy Department Los Angeles California 90027
Kaiser Permanente Medical Center San Diego California 92111
National Jewish Medical and Research Center Denver Colorado 80206
Washington University School of Medicine St Louis Missouri 63110
University of Wisconsin - Madison Madison Wisconsin 53792-3244

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00394329, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 1, 2018 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00394329 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →